VACCELERATE Clinical Studies
Clinical trials serve the purpose of clarifying open questions regarding new vaccines, therapies or medicines. By participating in clinical trials, you can make a major contribution to scientific progress. As a study participant you support the research of diseases and the development of new treatment options and at the same time receive comprehensive medical care.
›EU-COVAT-1 AGED: Phase 2, randomised trial to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines administration in older adults (≥75) already vaccinated against SARS-CoV-2 (3rd dose)
›EU-COVAT-2 BOOSTAVAC: Phase 2, randomised trial to determine the need for, optimal timing of and immunogenicity of administering a 3rd homologous mRNA vaccination dose against SARS-CoV-2 in the general population (18+ years) already fully vaccinated against SARS-CoV-2
›EU-COVPT-1 COVACC: Immunogenicity and reactogenicity of reduced COVID-19 mRNA vaccination regimens in children after 1st normal dose or SARS-COV-2 infection